Supply Chain Decarbonization

Supply Chain Decarbonization
Product Description

Most organisations face Scope 3 emissions as their largest decarbonization challenge. For many manufacturing, pharmaceutical, and chemical organisations, Scope 3 emissions can account for up to 90% of their total footprint, placing value-chain emissions under increasing regulatory and stakeholder scrutiny.

Progress is accelerating but consistently slowed by common organisational hurdles. Despite growing momentum, many organisations struggle with securing cross-business alignment, shifting from reporting to actual reductions, and scaling solutions across complex global supply chains.

ERM enables organisations to unlock value and accelerate meaningful reductions.ERM supports organisations in overcoming these barriers through deep technical expertise and supply chain experience, enabling rapid, measurable value creation while driving large-scale supplier decarbonization.

Read more Show less

ERM Europe

  • Country/Region:
    United Kingdom
  • Founded:
    1971
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    5000+
Company types
Consultancy
Primary activities
Other
View company profile
Categories
more categories Show less
Specifications
  • Details
    ERM helps companies move from Scope 3 measurement to real implementation & reductions - unlocking ROI, delivering resilience, and competitive advantage. 
More specifications Fewer specifications

ERM Europe

  • Country/Region:
    United Kingdom
  • Founded:
    1971
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    5000+
Company types
Consultancy
Primary activities
Other
View company profile

ERM Europe resources (2)

  • Pharmaceutical industry accelerates supply chain heat decarbonisation as Sanofi, UCB and Opella join AstraZeneca on Secaro and ERM’s Clean Heat Program

    News Pharmaceutical industry accelerates supply chain heat decarbonisation as Sanofi, UCB and Opella join AstraZeneca on Secaro and ERM’s Clean Heat Program

    Multinational pharmaceutical companies Sanofi, UCB and Opella have joined AstraZeneca as founding members of the Clean Heat Program, an initiative from supply chain intelligence network Secaro and global sustainability consultancy ERM. The program addresses the challenge of reducing industrial emissions by replacing fossil fuel-based heating with low-carbon alternatives, helping businesses overcome common barriers including limited expertise, insufficient supply chain engagement, funding constraints, and the complexity of upgrading heat systems.
    25 Sep 2026
  • Decarbonization that Pays Off: Value‑Led Strategies for Pharma Supply Chains

    Industry Webinar Decarbonization that Pays Off: Value‑Led Strategies for Pharma Supply Chains

    How leading pharma organizations are decarbonizing their supply chain

    Achieving meaningful decarbonization across pharmaceutical supply chains requires more than ambition: it demands clear roadmaps, cross‑functional alignment, and the ability to translate strategy into measurable action. Yet for many organisations, the path from intention to impact remains challenging.

    In this executive-level webinar, AstraZeneca and Takeda, along with ERM, will explore how leading pharma companies are moving from strategy to implementation, building actionable supply chain decarbonization roadmaps that deliver tangible results.

    2026-09-25